Search

Now showing items 1-1 of 1

Frequent evolution of copy number alterations in CLL following first-line treatment with FC(R) is enriched with TP53 alterations: results from the CLL8 trial

Edelmann, J. et al. (2017)

Wissenschaftlicher Artikel